Balyasny Asset Management’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,257
Closed -$331K 3336
2022
Q1
$331K Buy
+18,257
New +$262K ﹤0.01% 1904
2021
Q4
Sell
-30,883
Closed -$552K 2706
2021
Q3
$552K Buy
+30,883
New +$794K ﹤0.01% 1462

Other funds holding SGFY

Balyasny Asset Management's SGFY Position: Q2 2022 in Review

Balyasny Asset Management sold out of Signify Health, Inc. (SGFY) in Q2 2022, closing a stake of 18,257 shares — an estimated $331K sold.

Balyasny Asset Management first reported a position in SGFY in Q3 2021 and held it in 2 quarters. The position peaked at $552K in Q3 2021. 134 funds tracked by Wall St. Rank hold SGFY as of Q2 2022.

  • Balyasny Asset Management reported no remaining Signify Health, Inc. position as of Q2 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 18,257 Signify Health, Inc. shares in Q2 2022, an estimated $331K.
  • Balyasny Asset Management first reported a position in Signify Health, Inc. in Q3 2021 and held it in 2 quarters.
  • Balyasny Asset Management's Signify Health, Inc. position peaked at $552K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q2 2022.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.